B1.12 a novel peptide interacting with the extracellular loop of the EBV oncoprotein LMP1

Abstract : Latent membrane protein 1 (LMP1) encoded by the Epstein-Barr virus (EBV) plays an important role in EBV-induced cell transformation. Down-regulation of the LMP1 expression had shown promising results on cancer cell therapy. In this study, we identified by Phage display a novel peptide called B1.12 (ACPLDLRSPCG) which selectively binds to the extracellular loop (B1) of the LMP1 oncoprotein as demonstrated by molecular docking, NMR and ITC. Using an LMP1 expressing cell line, we showed that B1.12 decreased cell viability, and induced G0/G1 cell cycle arrest. In addition, the expression of A20, pAkt, and pNFkb (pRelA536) in C666-1 cells treated with B1.12 decreased compared to the untreated cells. In conclusion, we selected a novel peptide able to bind specifically to the extracellular loop of LMP1 and thus modulate its oncogenic properties.
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02086457
Contributor : Laurent Jonchère <>
Submitted on : Monday, April 1, 2019 - 1:09:36 PM
Last modification on : Monday, September 2, 2019 - 2:46:17 PM

Links full text

Identifiers

Citation

Nihel Ammous-Boukhris, Amor Mosbah, Wajdi Ayadi, Emna Sahli, Soizic Chevance, et al.. B1.12 a novel peptide interacting with the extracellular loop of the EBV oncoprotein LMP1. Scientific Reports, Nature Publishing Group, 2019, 9 (1), pp.4389. ⟨10.1038/s41598-019-39732-y⟩. ⟨hal-02086457⟩

Share

Metrics

Record views

32